Cargando…
Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364774/ https://www.ncbi.nlm.nih.gov/pubmed/28382252 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_14_17 |
| _version_ | 1782517393084383232 |
|---|---|
| author | Martins, Noel B. Chaput, Kimberly J. Stawicki, Stanislaw P. Modi, Ronak |
| author_facet | Martins, Noel B. Chaput, Kimberly J. Stawicki, Stanislaw P. Modi, Ronak |
| author_sort | Martins, Noel B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5364774 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53647742017-04-05 Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? Martins, Noel B. Chaput, Kimberly J. Stawicki, Stanislaw P. Modi, Ronak Int J Crit Illn Inj Sci Expert Commentary Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5364774/ /pubmed/28382252 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_14_17 Text en Copyright: © 2017 International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Expert Commentary Martins, Noel B. Chaput, Kimberly J. Stawicki, Stanislaw P. Modi, Ronak Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? |
| title | Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? |
| title_full | Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? |
| title_fullStr | Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? |
| title_full_unstemmed | Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? |
| title_short | Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? |
| title_sort | octreotide as an adjunct in the management of arterial gastrointestinal bleeding: should it be considered in refractory cases of obscure origin? |
| topic | Expert Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364774/ https://www.ncbi.nlm.nih.gov/pubmed/28382252 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_14_17 |
| work_keys_str_mv | AT martinsnoelb octreotideasanadjunctinthemanagementofarterialgastrointestinalbleedingshoulditbeconsideredinrefractorycasesofobscureorigin AT chaputkimberlyj octreotideasanadjunctinthemanagementofarterialgastrointestinalbleedingshoulditbeconsideredinrefractorycasesofobscureorigin AT stawickistanislawp octreotideasanadjunctinthemanagementofarterialgastrointestinalbleedingshoulditbeconsideredinrefractorycasesofobscureorigin AT modironak octreotideasanadjunctinthemanagementofarterialgastrointestinalbleedingshoulditbeconsideredinrefractorycasesofobscureorigin |